| Fighting against Skin Aging: The Way from Bench to Bedside |
50 |
| The Pros and Cons of Mesenchymal Stem Cell-Based Therapies |
27 |
| Olfactory Ensheathing Cells for Spinal Cord Injury: Sniffing Out the Issues |
22 |
| A Randomized, Placebo-Controlled Trial of Human Umbilical Cord Blood Mesenchymal Stem Cell Infusion for Children With Cerebral Palsy |
18 |
| Microenvironment Imbalance of Spinal Cord Injury |
18 |
| The Immunomodulatory Properties of Amniotic Cells: The Two Sides of the Coin |
17 |
| Mesenchymal Stem Cell-Derived Extracellular Vesicles Improve the Renal Microvasculature in Metabolic Renovascular Disease in Swine |
16 |
| Non-Coding RNA in Acute Ischemic Stroke: Mechanisms, Biomarkers and Therapeutic Targets |
16 |
| Preconditioning Enhances the Therapeutic Effects of Mesenchymal Stem Cells on Colitis Through PGE2-Mediated T-Cell Modulation |
14 |
| The Roles of MicroRNAs in Stroke: Possible Therapeutic Targets |
14 |
| Exosomes from Bone Marrow Mesenchymal Stem Cells Inhibit Neuronal Apoptosis and Promote Motor Function Recovery via the Wnt/beta-catenin Signaling Pathway |
13 |
| The Healing Effects of Conditioned Medium Derived from Mesenchymal Stem Cells on Radiation-Induced Skin Wounds in Rats |
13 |
| Exosomes and Stem Cells in Degenerative Disease Diagnosis and Therapy |
13 |
| CDNF Protein Therapy in Parkinson's Disease |
13 |
| The Efficacy and Safety of Mesenchymal Stem Cell Transplantation for Spinal Cord Injury Patients: A Meta-Analysis and Systematic Review |
13 |
| Historical Review: Opiate Addiction and Opioid Receptors |
12 |
| The Gut Microbiota in Multiple Sclerosis: An Overview of Clinical Trials |
12 |
| Mesenchymal Stem Cell Therapy in Stroke: A Systematic Review of Literature in Pre-Clinical and Clinical Research |
12 |
| Mapping of the Human Placenta: Experimental Evidence of Amniotic Epithelial Cell Heterogeneity |
11 |
| Transplanting Mesenchymal Stem Cells for Treatment of Ischemic Stroke |
11 |
| Roles of Pericytes in Stroke Pathogenesis |
11 |
| Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells |
11 |
| Exosomes Derived from IDO1-Overexpressing Rat Bone Marrow Mesenchymal Stem Cells Promote Immunotolerance of Cardiac Allografts |
11 |
| The impact of in vitro cell culture duration on the maturation of human cardiomyocytes derived from induced pluripotent stem cells of myogenic origin |
11 |
| Potential of Exosomes for the Treatment of Stroke |
10 |
| Enhancing the Therapeutic Potential of Olfactory Ensheathing Cells in Spinal Cord Repair Using Neurotrophins |
10 |
| Comparison of Mesenchymal Stromal Cells Isolated from Murine Adipose Tissue and Bone Marrow in the Treatment of Spinal Cord Injury |
10 |
| Extracellular Vesicles Derived from Wharton's Jelly Mesenchymal Stem Cells Prevent and Resolve Programmed Cell Death Mediated by Perinatal Hypoxia-Ischemia in Neuronal Cells |
10 |
| Cerebral Small Vessel Disease |
10 |
| A PEG-Based Hydrogel for Effective Wound Care Management |
9 |
| Dual Effects of Human Placenta-Derived Neural Cells on Neuroprotection and the Inhibition of Neuroinflammation in a Rodent Model of Parkinson's Disease |
9 |
| A circular RNA derived from MMP9 facilitates oral squamous cell carcinoma metastasis through regulation of MMP9 mRNA stability |
9 |
| Additional Use of Synovial Mesenchymal Stem Cell Transplantation Following Surgical Repair of a Complex Degenerative Tear of the Medial Meniscus of the Knee: A Case Report |
9 |
| Wharton's Jelly-Derived Mesenchymal Stem Cell Transplantation in a Patient with Hypoxic-Ischemic Encephalopathy: A Pilot Study |
9 |
| Mesenchymal Stem Cell Therapy of Pulmonary Fibrosis Improvement with Target Combination |
9 |
| A Case Series on Natural Conceptions Resulting in Ongoing Pregnancies in Menopausal and Prematurely Menopausal Women Following Platelet-Rich Plasma Treatment |
8 |
| Regulated Cell Death Seen through the Lens of Islet Transplantation |
8 |
| Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications |
8 |
| The Route by Which Intranasally Delivered Stem Cells Enter the Central Nervous System |
8 |
| Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017) |
8 |
| Placental Stem Cells from Domestic Animals: Translational Potential and Clinical Relevance |
8 |
| Angiopoietin-1 Mimetic Peptide Promotes Neuroprotection after Stroke in Type 1 Diabetic Rats |
8 |
| Stem Cell Therapy: A Promising Therapeutic Method for Intracerebral Hemorrhage |
8 |
| miR-145 Contributes to the Progression of Cervical Carcinoma by Directly Regulating FSCN1 |
7 |
| Inflammatory Responses are Sex Specific in Chronic Hypoxic-Ischemic Encephalopathy |
7 |
| Human Amniotic Membrane and Amniotic Membrane-Derived Cells: How Far Are We from Their Use in Regenerative and Reconstructive Urology? |
7 |
| MicroRNAs of Equine Amniotic Mesenchymal Cell-derived Microvesicles and Their Involvement in Anti-inflammatory Processes |
7 |
| MicroRNA-133a and Myocardial Infarction |
7 |
| Micro-RNAS Regulate Metabolic Syndrome-induced Senescence in Porcine Adipose Tissue-derived Mesenchymal Stem Cells through the P16/MAPK Pathway |
7 |
| In Vitro Long-Term Expansion and High Osteogenic Potential of Periodontal Ligament Stem Cells: More Than a Mirage |
7 |
